Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Antiallergic Drugs > EIDD-2801 for Sale > 3aR,4R,6R,6aR)-6-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate
3aR,4R,6R,6aR)-6-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate buy - large image1
3aR,4R,6R,6aR)-6-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate buy - image1

3aR,4R,6R,6aR)-6-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate

GMP 4 Inquiries

Unit Price: Get Latest Price
CAS No.:

2349386-89-4

Port:

Hyderabad

Packaging:

5kg/Drum

Price valid (until):

2021-07-30

Company Type:
Trader
Location:
India
Qualification:
Main Products:

Fenticonazole Nitrate Ph.Eur,Solifenacin Succinate IH/Ph.Eur,Rivaroxaban IH,Tioconazole Ph.Eur,Dithranol Ph. Eur,Rifaximin Ph. Eur

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Please enter the product introduction information...

    Molnupiravir is an experimental antiviral drug which is orally active and was developed for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine, and exerts its antiviral action through introduction of copying errors during viral RNA replication.

    Certificates

    Basic Info
    Product Name:

    EIDD-2801

    Other Name:

    EIDD 2801;EIDD-2801;EIDD2801;molnupiravir;2349386-89-4;MK-4482;UNII-YA84KI1VEW;YA84KI1VEW;Molnupiravir [USAN];((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate

    CAS No.:

    2349386-89-4

    Molecular Formula:

    C13H19N3O7

    InChIKeys:

    HTNPEHXGEKVIHG-QCNRFFRDSA-N

    Molecular Weight:

    329.31

    Exact Mass:

    329.12229995

    UNII:

    YA84KI1VEW

    NCI Thesaurus Code:

    C172633

    Categories:

    Antiallergic Drugs

    Characteristics
  • Seller Information
    Business Type:

    Trader

    Main Products:

    Fenticonazole Nitrate Ph.Eur,Solifenacin Succinate IH/Ph.Eur,Rivaroxaban IH,Tioconazole Ph.Eur,Dithranol Ph. Eur,Rifaximin Ph. Eur

    Location:

    2nd Floor, Sy No. 37/A & 37/P, Plot No. 6P, Signature Towers, Kothaguda, Kondapur, Hyderabad , Telangana India.

    Payment Terms:

    TT against copy of documents

    Average lead Time:

    35

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    301-500

    Year of Establishment:

    2004

    Certifications:

    GMP,GMP

    Company Profile

    >> Optimus was established in the year 2004 as custom synthesis laboratory by a team of Technocrats. It is one of the fastest growing
    Manufacturer in Active Pharmaceutical Ingredients (APIs) and Finished dosages.

    >> We expanded into global markets and started filing DMFs for both APIs and Intermediates with various Regulatory agencies.

    >> Optimus Research Center for API & Formulations was set-up as a centralized Research and Development center to focus on Generic
    product developments suitable for regulated markets.

    >> Optimus Pharma is an integrated pharmaceutical organization engaged in manufacturing of Solid Oral and semisolid formulations.

    >> We have dedicated API manufacturing plants and R&D Centres with a team of Scientists who had a passion towards chemistry and
    to ensure a better healthcare to everyone.

    >> We help our customers serve global markets with technology based, innovative, cost effective & consumer friendly products of the
    highest quality.

    >> In the journey of more than a decade Optimus developed many molecules and have emerged as one of the reputed manufacturing
    company in the industry.

    >> The Optimus group today employs directly about 950 people and provides indirect employment to about 600 across the group. The
    group has well qualified professionals from all fields and heading the various functional verticals of the Optimus Corporate Group.

  • Inquiry History
    4 Inquiries
    Country Product Purchase Quantity Date Posted
    Turkey

    EIDD-2801 Molnupiravir powder

    1 KG Jan 26, 2024
    Turkey

    Molnupiravir Api

    10 KG Feb 12, 2024
    Turkey

    Molnupiravir

    100 G Jul 24, 2024
    Turkey

    Molnupiravir

    100 G Dec 18, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.